JACC Cardiovasc Interv. 2022;15(13):1297-1309.
Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation Clubs.
제1저자 이학승, 김웅 · 교신저자 Goran Stankovic, 구본권
소속 (20)
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
- Division of Cardiology, Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
- Department of Cardiology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
- Institut Cardiovasculaire Paris Sud, Hopital Privé Jacques Cartier, Massy, France.
- Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Cardiovascular Medicine, Wakayama Medical University, Wakayama, Japan.
- University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom.
- Division of Cardiology, Department of Cardiovascular Center, Korea University Anam Hospital, Seoul, Korea.
- Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan; Department of Cardiology, Gifu Prefectural General Medical Center, Gifu, Japan.
- Cardiology Department of Reina Sofia Hospital, Maimonides Institute of Biomedical Research of Cordoba, University of Cordoba, Cordoba, Spain.
- Department of Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea.
- Department of Cardiovascular Medicine, Toyohashi Heart Center, Toyohashi, Japan.
- Division of Cardiovascular Medicine, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, United Kingdom.
- Department of Internal Medicine and Cardiovascular Research Institute, Keimyung University Dongsan Hospital, Daegu, Korea.
- Division of Cardiology, Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
- Department of Cardiovascular Medicine, Saga Medical Center KOSEIKAN, Saga, Japan.
- Division of Cardiovascular Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.
- Department of Cardiology B, Odense Universitates Hospital and University of Southern Denmark, Odense C, Denmark.
- Department of Cardiology, University Clinical Center of Serbia, and Faculty of Medicine, University of Belgrade, Belgrade, Serbia. Electronic address: gorastan@sbb.rs.
- Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Korea. Electronic address: bkkoo@snu.ac.kr.
Abstract
Coronary artery bifurcation lesions are frequently encountered in cardiac catheterization laboratories and are associated with more complex procedures and worse clinical outcomes than nonbifurcation lesions. Therefore, anatomical and physiological assessment of bifurcation lesions before, during, and after percutaneous coronary intervention is of paramount clinical importance. Physiological assessment can help interventionalists appreciate the hemodynamic significance of coronary artery disease and guide ischemia-directed revascularization. However, it is important to understand that the physiological approach for bifurcation disease is more important than simply using physiological indexes for its assessment. This joint consensus document by the Korean, Japanese, and European bifurcation clubs presents the concept of a physiological approach for coronary bifurcation lesions, as well as current knowledge, practical tips, pitfalls, and future directions of applying physiological indexes in bifurcation percutaneous coronary intervention. This document aims to guide interventionalists in performing appropriate physiology-based assessments and treatment decisions for coronary bifurcation lesions.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Keywords
bifurcationcoronary arteryphysiological indexesphysiologyrevascularization
Conflict of interest statement
Funding Support and Author Disclosures Dr Pan has received minor lecture fees from Abbott and Philips. Dr Banning has received institutional funding of a fellowship from Boston Scientific; and has received speaker fees from Boston Scientific, Abbott, Medtronic, Philips/Volcano, and Miracor. Dr Johnson has received consultancy and speaker fees from Abbott Vascular, Boston Scientific, and Terumo; and has received institutional funding for fellowships from Boston Scientific and Terumo. Dr Lefèvre has received speaker and proctorship fees from Abbott, Boston Scientific, Terumo, and Edwards Lifesciences. Dr Chatzizisis has received speaker honoraria, advisory board fees, and research grant support from Boston Scientific; and has received advisory board fees and research grant support from Medtronic. Dr Lassen has received speaker fees from Medtronic, Boston Scientific, Biotronik, Abbott, and Biosensors. Dr Stankovic has received speaker fees from Medtronic, Abbott, Boston Scientific, and Terumo. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
그 밖의 정보
- 출판 형태
- Journal Article, Review, Consensus Statement
- 저널
- JACC. Cardiovascular interventions · eISSN 1876-7605
- 전자 출판
- 2022-06-15
- MeSH
- Coronary Angiography · Coronary Artery Disease* / diagnostic imaging / therapy · Humans · Japan · Percutaneous Coronary Intervention* / adverse effects / methods · Republic of Korea · Treatment Outcome
- 연구비
- NHLBI NIH HHS R01 HL144690